Cancer News Headlines

EAST HARTFORD, Conn. (AP) — An 11-year study of the incidence of brain cancer at jet engine manufacturer Pratt & Whitney in the state ended Thursday with university researchers saying they found no statistically significant elevations in the rate of cancer among workers.

HARTFORD, Conn. (AP) — An 11-year study of the incidence of brain cancer at jet engine manufacturer Pratt & Whitney in the state ended Thursday with university researchers saying they found no statistically significant elevations in the rate of cancer among workers.

(Reuters) - Aveo Pharmaceuticals Inc said it was informed by its partner Astellas Pharma Inc that the Japanese company would not be seeking marketing approval for their experimental kidney cancer drug in Europe. Aveo shares fell about 13 percent in extended trade, after closing at $2.70 on the Nasdaq. They have lost about …

By Julie Steenhuysen CHICAGO (Reuters) - U.S. scientists say a dramatic result last year suggesting that a cancer drug already approved by U.S. regulators could quickly clear out Alzheimer's plaques in mice was too good to be true. The study, published last year in the journal Science, showed the skin cancer drug bexarotene …

By Andrew M. Seaman NEW YORK (Reuters Health) - Women in their 40s didn't cut back on mammograms during 2010, the year after a government-backed panel said annual breast cancer screening should be optional for them, says a new study. Researchers found that the odds of U.S. women between the ages of 40 and 49 getting a mammogram …

If you were to browse the iTunes music charts, it may surprise you to find that the top-selling song right now is by an artist you may have never heard of: Zach Sobiech's "Clouds" has landed at No. 1 with its inspirational message of hope and courage. In 2009, when Zach was just 14 years [...]

By Paul Sandle LONDON (Reuters) - British pharmaceutical company BTG announced two deals on Thursday that it said could create an interventional medicine business with potential sales of $1 billion. Chief Executive Louise Makin told Reuters the deals would more than double BTG's revenues in the fast-growing market of targeting …

LONDON (Reuters) - Britain's BTG said it would make two acquisitions, one extending its expertise in liver cancer and the other a treatment for severe blood clots, to create an interventional medicine business with potential sales of $1 billion. The company said on Thursday it had agreed to buy the targeted therapies division …

By Julie Steenhuysen CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer. Jansen's next vaccine success …

By Genevra Pittman NEW YORK (Reuters Health) - More than one quarter of people being treated for non-melanoma skin cancer in their doctor's office reported some type of complication after surgery, in a new study. About half of those complications were medical problems related to the cancer-removing procedure, including …

By Bill Berkrot NEW YORK (Reuters) - Little known biotechnology company Merrimack Pharmaceuticals Inc has quietly built a large pipeline of experimental cancer treatments that it aims to deliver at a fraction of the cost spent by larger rivals. That could translate into lower-cost treatments for large unmet needs, such …

A little boy's dying wish came true, thanks to Dame Helen Mirren. Oliver Burton is a 10-year-old boy with Down syndrome who has fought different forms of cancer for nearly his entire life. He was recently diagnosed with terminal spine and bone marrow cancer. Oliver requested to visit Buckingham Palace and have afternoon …

Shares of Oncolytics Biotech Inc. rose Wednesday after the company reported promising results for its drug Reolysin as a treatment for melanoma, the deadliest form of skin cancer. Oncolytics said it is ...

The American Cancer Society — one of the nation's best known and influential health advocacy groups — is 100 years old this week. Back in 1913 when it was formed, cancer was a lesser threat for most Americans. ...

(Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients with metastatic melanoma, a type of skin cancer. Shares of the Calgary-based company rose as much as 11 percent to C$3.14 on the Toronto Stock …

Bristol-Myers Squibb could be a big winner with a portfolio of cancer treatments under development that use a patient's own immune system to attack the disease, according to a Citi, which raised its rating ...

KING OF PRUSSIA, Pa. (AP) — Three sisters say they were kicked out of a suburban Philadelphia mall after refusing to remove profanity-laden hats expressing their hatred of breast cancer.

By Ben Hirschler LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. That bullish sales forecast by analysts at U.S. bank Citigroup highlights the growing excitement surrounding so-called …

In a story May 20 about Pfizer Inc. halting a cancer drug study, The Associated Press erroneously reported the uses of two of the drugmaker's existing cancer medicines. Bosulif is approved for use in certain ...

By Ivan Oransky NEW YORK (Reuters Health) - The importance of health literacy hit home for Lisa Gualtieri when a Cambodian refugee diagnosed with cancer asked her to act as a patient advocate. She played the role of a "salty tongue," a Cambodian expression that paints outspokenness in a positive light. But even though the …

Winning the War against Cervical Cancer

When he was 14, Zach Sobiech was diagnosed with osteosarcoma, a rare bone cancer. Doctors told Sobiech that he would have only a year left to live.

Keyboardist Ray Manzarek of The Doors dies at age 74 LOS ANGELES (Reuters) - Ray Manzarek, a founding member and keyboardist of 1960s rock group The Doors, died on Monday at a medical clinic in Germany at age 74 following a battle with cancer, the group's manager Tom Vitorino said. Manzarek, who lived in Northern California's …